Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics
September 07 2021 - 8:30AM
Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical
technology company focused on designing, developing and marketing
products that improve the quality of life for patients who suffer
from neurohealth disorders, and Zion Healing, Inc., a leading
franchisor of Behavioral Health services and Transcranial Magnetic
Stimulation (TMS), announced today a new agreement under which
Neuronetics will be the exclusive supplier of TMS equipment to Zion
Healing, Inc. and its franchisees. Zion Healing, Inc. is one of the
first and only companies to offer a scalable model for franchising
of Mental and Behavioral Health Clinics.
“We cannot open clinics fast enough to meet the needs of this
growing market,” said Robert Beatty, CEO of Zion Healing, Inc. “The
level of support and training that NeuroStar brings to our
franchise model goes well beyond any expectation that we have for
an industry partner. The Neuronetics team is simply the best in the
industry when it comes to supporting our team and our
patients.”
NeuroStar® Advanced Therapy is a non-invasive, non-drug
treatment option that uses transcranial magnetic stimulation (TMS)
to target key areas of the brain that are underactive in people
with depression. NeuroStar is the leading TMS treatment for
depression in adult patients who have failed to achieve
satisfactory improvement from prior antidepressant medication in
the current episode. NeuroStar has been proven to be safe and
effective with over 4 million treatments delivered to 110,000
patients to date.
“The franchise model that Zion Healing is pioneering has the
potential to allow countless more people to receive NeuroStar
treatment, at a time when the mental health of so many is
suffering,” said Keith J. Sullivan, President and CEO of
Neuronetics. “Zion Healing’s unique approach to treating mental
health issues, as well as their compassionate approach to patient
care, are two of the reasons we wanted to enter into this
partnership and are excited about its long-term potential.”
To learn more about NeuroStar® Advanced Therapy, visit
www.neurostar.com. To learn more about Zion Healing, Inc., visit
www.zionhealing.com.
About Neuronetics, Inc.Neuronetics, Inc.
believes that mental health is as important as physical health. As
a global leader in neuroscience and the largest TMS company in the
industry, Neuronetics is redefining patient and physician
expectations by designing and developing products that improve the
quality of life for people suffering from neurohealth conditions.
An FDA-cleared, non-drug, noninvasive treatment for people with
depression, Neuronetics’ NeuroStar® Advanced Therapy system is
today’s leading transcranial magnetic stimulation (TMS) treatment
for major depressive disorder in adults with over four million
treatments delivered. NeuroStar is widely researched and backed by
the largest clinical data set of any TMS system for depression,
including the world’s largest depression Outcomes Registry.
Neuronetics is committed to transforming lives by offering an
exceptional treatment option that produces extraordinary results.
For safety information and indications for use, visit
NeuroStar.com.
Media Contact:Neuronetics,
Inc.EvolveMKD646.517.4220NeuroStar@evolvemkd.com
About Zion Healing, Inc.
Zion Healing, Inc. sells and grants Franchises
to operate treatment centers for Mental Health Disorders for Youth
and Adults to be located generally in regional cities in the United
States. Each Franchise will do business and operate under the
trademarks of Zion Healing and Zion Healing Centers. The Company
has operated varying forms and functions of Residential Inpatient
Treatment Centers, Outpatient Services, Counseling, and Mental
Health Therapies in Utah for over 8 years under the separate
companies of The Retreat at Zion and Zion Recovery. For more
information, please visit, www.zionhealing.com.
Media Contact:Zion Healing Inc. Rod
Goodman 208-818-0466 rod@zionhealing.com
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Sep 2023 to Sep 2024